
August 28, 2015 Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, Synjardy, type 2 diabetes

August 28, 2015 Medical Communications, Research and Development Amgen, FDA, Repatha, evolocumab

August 28, 2015 Medical Communications, Research and Development ALN-PCScs, Repatha, alirocumab, cardiology, cardiovascular disease, cvd, evolocumab, heart disease, high cholesterol, praluent
August 27, 2015 Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, mergers and acquisitions

August 27, 2015 Research and Development, Sales and Marketing Cancer, MD Anderson Cancer Center, immatics, keytruda

August 26, 2015 Research and Development, Sales and Marketing Alimta, Eli Lilly, Teva Pharmaceutical, lung cancer

August 26, 2015 Manufacturing and Production, Research and Development Novo Nordisk, manufacturing

August 26, 2015 Research and Development clinical trial transparency, clinical trials, health research authority, transparency

August 26, 2015 Research and Development Novo Nordisk, Victoza, diabetes, insulin

August 26, 2015 Research and Development Ebola, Ebola virus, Ebola virus disease, Toyama Chemical, VSV-ZEBOV, favipiravir, zmapp

August 26, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Eli Lilly, Lantus, abasaglar, basal insulin, biosimilar, biosimilars, diabetes, insuling glargine, lilly

August 25, 2015 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Briggs Morrison, Sean Bohen
August 24, 2015 Research and Development ABPI, PMCPA, clinical trial transparency, clinical trials, health research authority, transparency

August 24, 2015 Research and Development

August 24, 2015 Research and Development AstraZeneca, Cancer, MEDI4736, Peregrine, Peregrine Pharmaceuticals, bavituximab, durvalumab, immunoncology, immunotherapy, oncology, tumours